Microscopic colitis, a form of inflammatory bowel disease, has no cure, but it's possible to enter remission. Learn more here ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...

People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most ...

This Review summarizes the latest data on the pathophysiology, epidemiology, clinical features, histopathology, and treatment of these more recently characterized and rare forms of colitis and ...

The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...

Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as ...

Crohn's disease and ulcerative colitis are idiopathic ... patients for whom the natural history of disease and response to treatment are predictable. The most widely held hypothesis on the ...

Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, drives the growth of the market David Correa Allied Market Research + 1 800-792-5285 ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.